Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma - Contacts and Locations

Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma

This study is currently recruiting participants.
Information provided by Duke University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00510887

Contacts


Contact: Patty Davis, RN	919-668-1026	davis043@mc.duke.edu

Locations


United States, North Carolina
	Duke University Medical Center	Recruiting
	Durham, North Carolina, United States, 27710
	Contact: Patty Davis, RN 919-668-1026 davis043@mc.duke.edu
	Contact: Donna Adams, RN 919-668-4716 adams068@mc.duke.edu
	Principal Investigator: David A. Rizzieri, MD

Sponsors and Collaborators

Duke University

Millennium Pharmaceuticals

Investigators


Principal Investigator:	David A Rizzieri, MD	Duke University